Fool.com contributor Parkev Tatevosian analyzes Hims and Hers (HIMS 1.18%) stock to answer if it makes an excellent buy at current valuations.
*Stock prices used were the afternoon prices of Sept. 19, 2023. The video was published on Sept. 21, 2023.

The healthcare company is demonstrating excellent revenue growth.
Fool.com contributor Parkev Tatevosian analyzes Hims and Hers (HIMS 1.18%) stock to answer if it makes an excellent buy at current valuations.
*Stock prices used were the afternoon prices of Sept. 19, 2023. The video was published on Sept. 21, 2023.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.